|
gptkbp:instanceOf
|
gptkb:Fungi
|
|
gptkbp:affects
|
immunocompromised individuals
|
|
gptkbp:antifungalResistance
|
gptkb:fluconazole
|
|
gptkbp:antifungalSusceptibility
|
gptkb:voriconazole
gptkb:amphotericin_B
itraconazole
|
|
gptkbp:biosafetyLevel
|
gptkb:BSL-2
laboratory-acquired infection risk
|
|
gptkbp:canGrowOn
|
mold at 25°C
yeast at 37°C
|
|
gptkbp:cause
|
talaromycosis
|
|
gptkbp:class
|
gptkb:Eurotiomycetes
|
|
gptkbp:diagnosedBy
|
gptkb:culture
microscopy
molecular methods
|
|
gptkbp:discoveredBy
|
Hubert Marneffe
|
|
gptkbp:discoveredIn
|
1956
|
|
gptkbp:family
|
gptkb:Trichocomaceae
|
|
gptkbp:firstIsolatedFrom
|
gptkb:bamboo_rat
|
|
gptkbp:formerName
|
gptkb:Penicillium_marneffei
|
|
gptkbp:foundIn
|
gptkb:Southeast_Asia
gptkb:Southern_China
gptkb:Northeast_India
|
|
gptkbp:genus
|
gptkb:Talaromyces
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Talaromyces marneffei
|
|
gptkbp:kingdom
|
gptkb:Fungi
|
|
gptkbp:morphologicalType
|
dimorphic fungus
|
|
gptkbp:notableFeature
|
produces red pigment on culture
|
|
gptkbp:notableFor
|
HIV/AIDS patients
|
|
gptkbp:order
|
gptkb:Eurotiales
|
|
gptkbp:phylum
|
gptkb:Ascomycota
|
|
gptkbp:reservoirName
|
bamboo rats
|
|
gptkbp:riskFactor
|
immunosuppressed patients
|
|
gptkbp:symptom
|
gptkb:anemia
fever
weight loss
cough
hepatosplenomegaly
lymphadenopathy
skin lesions
|
|
gptkbp:transmittedBy
|
inhalation of spores
|
|
gptkbp:treatment
|
gptkb:amphotericin_B
itraconazole
|
|
gptkbp:zoonotic
|
yes
|
|
gptkbp:bfsParent
|
gptkb:Talaromyces
gptkb:Penicillium_marneffei
|
|
gptkbp:bfsLayer
|
7
|